Cargando…

Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function

BACKGROUND: CD4 T-cell decay is variable among HIV-infected individuals. In exceptional cases, CD4 T-cell counts remain stable despite high plasma viremia. HIV envelope glycoprotein (Env) properties, namely tropism, fusion or the ability to induce the NK ligand NKp44L, or host factors that modulate...

Descripción completa

Detalles Bibliográficos
Autores principales: Curriu, Marta, Fausther-Bovendo, Hughes, Pernas, María, Massanella, Marta, Carrillo, Jorge, Cabrera, Cecilia, López-Galíndez, Cecilio, Clotet, Bonaventura, Debré, Patrice, Vieillard, Vincent, Blanco, Julià
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270019/
https://www.ncbi.nlm.nih.gov/pubmed/22312424
http://dx.doi.org/10.1371/journal.pone.0030330
_version_ 1782222535476117504
author Curriu, Marta
Fausther-Bovendo, Hughes
Pernas, María
Massanella, Marta
Carrillo, Jorge
Cabrera, Cecilia
López-Galíndez, Cecilio
Clotet, Bonaventura
Debré, Patrice
Vieillard, Vincent
Blanco, Julià
author_facet Curriu, Marta
Fausther-Bovendo, Hughes
Pernas, María
Massanella, Marta
Carrillo, Jorge
Cabrera, Cecilia
López-Galíndez, Cecilio
Clotet, Bonaventura
Debré, Patrice
Vieillard, Vincent
Blanco, Julià
author_sort Curriu, Marta
collection PubMed
description BACKGROUND: CD4 T-cell decay is variable among HIV-infected individuals. In exceptional cases, CD4 T-cell counts remain stable despite high plasma viremia. HIV envelope glycoprotein (Env) properties, namely tropism, fusion or the ability to induce the NK ligand NKp44L, or host factors that modulate Env cytopathic mechanisms may be modified in such situation. METHODS: We identified untreated HIV-infected individuals showing non-cytopathic replication (VL>10,000 copies/mL and CD4 T-cell decay<50 cells/µL/year, Viremic Non Progressors, VNP) or rapid progression (CD4 T-cells<350 cells/µL within three years post-infection, RP). We isolated full-length Env clones and analyzed their functions (tropism, fusion activity and capacity to induce NKp44L expression on CD4 cells). Anti-Env humoral responses were also analyzed. RESULTS: Env clones isolated from VNP or RP individuals showed no major phenotypic differences. The percentage of functional clones was similar in both groups. All clones tested were CCR5-tropic and showed comparable expression and fusogenic activity. Moreover, no differences were observed in their capacity to induce NKp44L expression on CD4 T cells from healthy donors through the 3S epitope of gp41. In contrast, anti- Env antibodies showed clear functional differences: plasma from VNPs had significantly higher capacity than RPs to block NKp44L induction by autologous viruses. Consistently, CD4 T-cells isolated from VNPs showed undetectable NKp44L expression and specific antibodies against a variable region flanking the highly conserved 3S epitope were identified in plasma samples from these patients. Conversely, despite continuous antigen stimulation, VNPs were unable to mount a broad neutralizing response against HIV. CONCLUSIONS: Env functions (fusion and induction of NKp44L) were similar in viremic patients with slow or rapid progression to AIDS. However, differences in humoral responses against gp41 epitopes nearby 3S sequence may contribute to the lack of CD4 T cell decay in VNPs by blocking the induction of NKp44L by gp41.
format Online
Article
Text
id pubmed-3270019
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-32700192012-02-06 Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function Curriu, Marta Fausther-Bovendo, Hughes Pernas, María Massanella, Marta Carrillo, Jorge Cabrera, Cecilia López-Galíndez, Cecilio Clotet, Bonaventura Debré, Patrice Vieillard, Vincent Blanco, Julià PLoS One Research Article BACKGROUND: CD4 T-cell decay is variable among HIV-infected individuals. In exceptional cases, CD4 T-cell counts remain stable despite high plasma viremia. HIV envelope glycoprotein (Env) properties, namely tropism, fusion or the ability to induce the NK ligand NKp44L, or host factors that modulate Env cytopathic mechanisms may be modified in such situation. METHODS: We identified untreated HIV-infected individuals showing non-cytopathic replication (VL>10,000 copies/mL and CD4 T-cell decay<50 cells/µL/year, Viremic Non Progressors, VNP) or rapid progression (CD4 T-cells<350 cells/µL within three years post-infection, RP). We isolated full-length Env clones and analyzed their functions (tropism, fusion activity and capacity to induce NKp44L expression on CD4 cells). Anti-Env humoral responses were also analyzed. RESULTS: Env clones isolated from VNP or RP individuals showed no major phenotypic differences. The percentage of functional clones was similar in both groups. All clones tested were CCR5-tropic and showed comparable expression and fusogenic activity. Moreover, no differences were observed in their capacity to induce NKp44L expression on CD4 T cells from healthy donors through the 3S epitope of gp41. In contrast, anti- Env antibodies showed clear functional differences: plasma from VNPs had significantly higher capacity than RPs to block NKp44L induction by autologous viruses. Consistently, CD4 T-cells isolated from VNPs showed undetectable NKp44L expression and specific antibodies against a variable region flanking the highly conserved 3S epitope were identified in plasma samples from these patients. Conversely, despite continuous antigen stimulation, VNPs were unable to mount a broad neutralizing response against HIV. CONCLUSIONS: Env functions (fusion and induction of NKp44L) were similar in viremic patients with slow or rapid progression to AIDS. However, differences in humoral responses against gp41 epitopes nearby 3S sequence may contribute to the lack of CD4 T cell decay in VNPs by blocking the induction of NKp44L by gp41. Public Library of Science 2012-02-01 /pmc/articles/PMC3270019/ /pubmed/22312424 http://dx.doi.org/10.1371/journal.pone.0030330 Text en Curriu et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Curriu, Marta
Fausther-Bovendo, Hughes
Pernas, María
Massanella, Marta
Carrillo, Jorge
Cabrera, Cecilia
López-Galíndez, Cecilio
Clotet, Bonaventura
Debré, Patrice
Vieillard, Vincent
Blanco, Julià
Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function
title Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function
title_full Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function
title_fullStr Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function
title_full_unstemmed Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function
title_short Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function
title_sort viremic hiv infected individuals with high cd4 t cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and function
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270019/
https://www.ncbi.nlm.nih.gov/pubmed/22312424
http://dx.doi.org/10.1371/journal.pone.0030330
work_keys_str_mv AT curriumarta viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction
AT faustherbovendohughes viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction
AT pernasmaria viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction
AT massanellamarta viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction
AT carrillojorge viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction
AT cabreracecilia viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction
AT lopezgalindezcecilio viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction
AT clotetbonaventura viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction
AT debrepatrice viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction
AT vieillardvincent viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction
AT blancojulia viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction